Printer Friendly
The Free Library
14,503,922 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Research and Markets: Basic Platform Report: Prostate Cancer.


DUBLIN, Ireland -- Prostate Cancer Therapeutics Analysed: a Solid Presentation of the Exciting and Rapidly Evolving Area

Research and Markets (http://www.researchandmarkets.com) has announced the addition of Basic Platform Report: Prostate Cancer to their offering.

This "Basic Platform Report: Prostate Cancer", provides a complete and systematic description of the current market of already established, as well as new innovative therapies for the treatment of prostate cancer.

In this informative report, extensive presentations of more than 200 selected companies active in this field are included.

The aim of this report has been to review the cancer research activities and partnerships in different therapeutic strategies.

Hundreds of pipeline drugs and a majority of alliances are described.

Each company profile contains contact data, a short description of the company, partnership activities, pipeline, patents and description of products already at market.

With the help of the complete company index of more than 200 firms and collaboration tables, any player in the field can be easily tracked down.

This "Basic Platform Report: Prostate Cancer" is an excellent source of information that provides a solid presentation of the exciting and rapidly evolving area of prostate cancer therapeutics.

Some of the drugs included in the report:

Avodart, Zoladex, Proscar, Casodex, Taxotere, Satraplatin, Plenaxis, EULEXIN, Trelstar Depot, Trelstar LA, Viadur, Gleevec, Avastin, Herceptin, Atrasentan, Acapodene, Actimid, OSI-461, Revimid, Eladem, GTI-2501, ILX-651, calcitrol, Genasense, Provenge , GVAX, SGN-15, Thalomid, Velcade, Lupron Depot, Histrelin, Eligard, ILX651, Vitaxin, J591, CG7870, BBR-3576, PCK PCK Pedagogical Content Knowledge (knowledge of how to teach a subject)
PCK Phosphoenolpyruvate Carboxykinase
PCK Polycystic Kidney Disease
PCK Phua Chu Kang (Singapore sitcom character) 
3145, Leuvectin, Leuprolide, ProMaxx-100, Osaterone, Prinomastat, BLP BLP Barbados Labour Party
BLP Bible Literacy Project
BLP Bypass Label Processing (IBM)
BLP Buddhist Liberal Party (Cambodia)
BLP Bonded Logistics Park
BLP Borland Learning Partner
25, Metaret, Chimax, Drogenil, Flutamide, EULEXIN, Onconase, IM862, MDX-010, Erbitux, Eladem, GTI-2040, Apomine, Eflornithine, Doxil, GTI-2501, Thalidomide thalidomide (thəlĭd`əmĭd'), sleep-inducing drug found to produce skeletal defects in developing fetuses. The drug was marketed in Europe, especially in West Germany and Britain, from 1957 to 1961, and was thought to be so safe that , TG4010, KRX-0401, Yondelis, TRICOM TRICOM Transportation Research Implementation Consortium for Operations and Management  Vaccine, Zarnestra

Some of the companies included in the report:

Aventis, Aeterna Laboratories Inc, Abbott Laboratories, Celgene, Cell Genesys, Cytogen Corporation, Dendreon, GlaxoSmithKline, GTx, Inc, Medimmune, Millennium Pharmaceuticals, Inc, Procyon BioPharma, Novacea Inc., Teikoku Hormone, Pfizer (Pharmacia), Paladin Paladin

archetypal gunman who leaves a calling card. [TV: Have Gun, Will Travel in Terrace, I, 341]

See : Wild West
 Labs/ Hydro Med Sciences, Novartis, Praecis Pharmaceuticals, Biomira, Spectrum Pharmaceuticals, ALZA, Medarex, ImClone,. BMS BMS
abbr.
Bachelor of Marine Science
, Merck, Immuno-Designed Molecules (IDM (1) See identity management.

(2) (Integrated Device Manufacturer) A company that performs every step of the chip-making process, including design, manufacture, test and packaging. Examples of IDMs are Intel, AMD, Motorola, IBM, TI and Lucent.
), Lorus Therapeutics, ILEX Ilex

a bush bearing berries containing saponins; cause vomiting, diarrhea. Called also holly.
 Oncology, Keryx Biopharmaceuticals

Report Contents:

For more information visit http://www.researchandmarkets.com/reports/c4943
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 14, 2004
Words:341
Previous Article:SMOC Subsidiary, SMO Multimedia Corporation Appoints Robert Gallner President.
Next Article:Research and Markets: Analytical Tool: Avastin & The Competitive Landscape.



Related Articles
Vasectomy, prostate cancer: unexplained link.
Teams implicate new gene in prostate cancer.(Brief Article)
TO YOUR HEALTH BOOKS.(L.A. Life)
CURE FOR PROSTATE CANCERS? HUMAN TESTS TO START ON PROMISING NEW DRUG.(News)
PULSE CONQUERING CANCER.(U)
Predicting prostate cancer's moves: new tests could refine therapy decisions.
ROSEY GRIER LOOKS TO BLITZ PROSTATE CANCER.(U)
Prostate Tales: Men's Experiences with Prostate Cancer.(Book Review)
Prostate Tales: men's experiences with prostate cancer.(Brief Article)(Book Review)
Prostate Tales: men's experiences with prostate cancer.(Brief Article)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles